Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

Mikkel Østergaard; Bo Baslund; W Rigby; B Rojkovich; C Jorgensen; P T Dawes; Charlotte Wiell; D J Wallace; S C Tamer; H Kastberg; J Petersen; S Sierakowski

doi:10.1002/art.30097

Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

Mikkel Østergaard, Bo Baslund, W Rigby, B Rojkovich, C Jorgensen, P T Dawes, Charlotte Wiell, D J Wallace, S C Tamer, H Kastberg, J Petersen, S Sierakowski

Abstract

Udgivelsesdato: 2011-Jan

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	63
Udgave nummer	1
Sider (fra-til)	305
Antal sider	1
ISSN	0004-3591
DOI	https://doi.org/10.1002/art.30097
Status	Udgivet - 2011

Adgang til dokumentet

10.1002/art.30097

Citationsformater

Østergaard, M., Baslund, B., Rigby, W., Rojkovich, B., Jorgensen, C., Dawes, P. T., Wiell, C., Wallace, D. J., Tamer, S. C., Kastberg, H., Petersen, J., & Sierakowski, S. (2011). Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al". Arthritis & Rheumatism, 63(1), 305. https://doi.org/10.1002/art.30097

Østergaard, M , Baslund, B, Rigby, W, Rojkovich, B, Jorgensen, C, Dawes, PT, Wiell, C, Wallace, DJ, Tamer, SC, Kastberg, H, Petersen, J & Sierakowski, S 2011, 'Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"', Arthritis & Rheumatism, bind 63, nr. 1, s. 305. https://doi.org/10.1002/art.30097

@article{8144e8d0221a468eaddcccd626b16e5c,

title = "Reply to {"}Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by {\O}stergaard et al{"}",

abstract = "Udgivelsesdato: 2011-Jan",

author = "Mikkel {\O}stergaard and Bo Baslund and W Rigby and B Rojkovich and C Jorgensen and Dawes, {P T} and Charlotte Wiell and Wallace, {D J} and Tamer, {S C} and H Kastberg and J Petersen and S Sierakowski",

year = "2011",

doi = "10.1002/art.30097",

language = "English",

volume = "63",

pages = "305",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

AU - Østergaard, Mikkel

AU - Baslund, Bo

AU - Rigby, W

AU - Rojkovich, B

AU - Jorgensen, C

AU - Dawes, P T

AU - Wiell, Charlotte

AU - Wallace, D J

AU - Tamer, S C

AU - Kastberg, H

AU - Petersen, J

AU - Sierakowski, S

PY - 2011

Y1 - 2011

N2 - Udgivelsesdato: 2011-Jan

AB - Udgivelsesdato: 2011-Jan

U2 - 10.1002/art.30097

DO - 10.1002/art.30097

M3 - Comment/debate

C2 - 20967851

SN - 0004-3591

VL - 63

SP - 305

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 1

ER -